Table 1

Demographic and clinical characteristics of study subjects with metastatic lung cancer receiving chemotherapy

Parameter

Value


n = 4068

Age (n,%)

18-34

20

0.5

35-44

108

2.7

45-54

513

12.6

55-64

1,481

36.4

> = 65

1,946

47.8

Geographic region (n,%)

Northeast

538

13.2

Northcentral

1,249

30.7

South

2,071

50.9

West

208

5.1

Payer type (n,%)

HMO

81

2.0

Indemnity

1,814

44.6

PPO

1,210

29.7

POS

941

23.1

Other

21

0.5

Comorbidities (n,%)

Cerebrovascular Disease

426

10.5

Coronay heart disease

910

22.4

Heart failure

66

1.6

Peripheral arterial disease

165

4.1

Diabetes

808

19.9

Kidney Disease

60

1.5

Liver Disease

272

6.7

Respiratory Disease

2,384

58.6

Health care expenditures prior to index date (mean, SD)

-365 days

28,562

31,136


Vera-Llonch et al. BMC Health Services Research 2011 11:305   doi:10.1186/1472-6963-11-305

Open Data